CD4 and neoplasm: In agreement with the above finding, Tlr2−/− mice bearing B16F10 tumors had a significant reduction of IL-21+ and IL-10+ CD4+ T cells in the tumor tissue compared to WT tumor-bearing mice (Fig. 2e, f).